• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

    6/27/23 1:56:02 PM ET
    $ACET
    $ACIU
    $AEL
    $AKU
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACET alert in real time by email

    Gainers

    • Tivic Health Systems, Inc. (NASDAQ:TIVC) shares jumped 105% to $0.2050 after the company signed a distribution agreement with Cardinal Health.
    • Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) surged 76.3% to $3.2450 after the company announced initial dose escalation data demonstrated anti-tumor activity of BDTX-1535 in non-small cell lung cancer patients across multiple EGFR mutation families.
    • Centogene N.V. (NASDAQ:CNTG) rose 49% to $1.1675 after the company and Lifera formed a Saudi Arabian joint venture. Under the terms of the collaboration, the company will receive a $30 million mandatory convertible loan from Lifera.
    • CalciMedica, Inc. (NASDAQ:CALC) climbed 37% to $4.43.
    • Cara Therapeutics, Inc. (NASDAQ:CARA) gained 22.1% to $3.9547. Cara Therapeutics was granted U.S. Patent #11684674: Oral formulations of kappa opioid receptor agonists.
    • AC Immune SA (NASDAQ:ACIU) rose 19.2% to $2.36 after the company received FDA fast track designation for anti-amyloid-beta active immunotherapy, ACI-24.060 for Alzheimer's disease.
    • American Equity Investment Life Holding Company (NYSE:AEL) shares gained 17.6% to $53.02 after the company announced it has received a $55 per share acquisition proposal from Brookfield Reinsurance.
    • American Rebel Holdings, Inc. (NASDAQ:AREB) jumped 16.6% to $5.47.
    • Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) rose 16.6% to $0.0729.
    • IronNet, Inc. (NYSE:IRNT) gained 14.8% to $0.2067 after dropping 13% on Monday.
    • Astrotech Corporation (NASDAQ:ASTC) gained 13.5% to $12.95. Astrotech 13D filing showed BML Investment Partners, L.P. increased stake in the company to 13%.
    • Aterian, Inc. (NASDAQ:ATER) rose 13% to $0.4099.
    • Enovix Corporation (NASDAQ:ENVX) gained 12.1% to $14.71 after the company announced it received a purchase order to produce battery cells for the U.S. Army.
    • WeWork Inc. (NYSE:WE) rose 11.1% to $0.2601.
    • Moolec Science SA (NASDAQ:MLEC) gained 10.7% to $4.1817.
    • Edgewise Therapeutics, Inc. (NASDAQ:EWTX) rose 9.9% to $7.54 as the company released 12-month topline results from the ARCH study, an open-label, single-center study assessing EDG-5506 in adults with Becker Muscular Dystrophy (BMD).
    • NextPlay Technologies, Inc. (NASDAQ:NXTP) surged 9.7% to $1.13.
    • Ispire Technology Inc. (NASDAQ:ISPR) rose 9.6% to $8.52 after the company announced it raised roughly $8 million in a private placement of common stock.
    • Unity Software Inc. (NYSE:U) gained 9.2% to $40.10 after the company announced a new AI marketplace and Wells Fargo initiated coverage on the stock with an Overweight rating and $48 price target.
    • InnSuites Hospitality Trust (NYSE:IHT) shares rose 8.8% to $2.84 after gaining 13% on Monday.
    • BIOLASE, Inc. (NASDAQ:BIOL) shares gained 8.3% to $0.0852. Biolase was recently notified by Nasdaq that the company did not meet the minimum closing bid price requirement of $1.00 for continued listing.
    • View, Inc. (NASDAQ:VIEW) shares climbed 8.2% to $0.13 after declining around 10% on Monday. View recently filed a new patent application titled "Environmental Adjustment Using Artificial Intelligence."
    • OneConnect Financial Technology Co., Ltd. (NASDAQ:OCFT) shares gained 7.4% to $2.9650 after dropping 33% on Monday. The company recently reported first-quarter sales of $135.33 million, missing the consensus estimate of $143.91 million.

    Losers

    • Adicet Bio, Inc. (NASDAQ:ACET) dropped 53.2% to $2.18 after the company shared safety and efficacy data from its Phase 1 study of ADI-001 for relapsed or refractory aggressive B-cell non-Hodgkin's lymphoma (NHL). JMP Securities downgraded Adicet Bio to Market Perform from Market Outperform rating.
    • Siyata Mobile Inc. (NASDAQ:SYTA) dipped 40% to $0.0533 after the company priced a 50 million share offering at $0.045 per share.
    • Lordstown Motors Corp. (NASDAQ:RIDE) shares fell 31.3% to $1.90 after the company opted to file for Chapter 11 bankruptcy protection.
    • Xponential Fitness, Inc. (NYSE:XPOF) fell 30.2% to $17.52. Fuzzy Panda Research issued a short report titled 'Xponential Fitness (XPOF) – "Abusive Franchisor That Is A House Of Cards."'
    • Nkarta, Inc. (NASDAQ:NKTX) dropped 26.6% to $3.3250 after the company released updated data from its Phase 1 study of NKX101 for relapsed or refractory acute myeloid leukemia.
    • Yellow Corporation (NASDAQ:YELL) declined 24.6% to $0.9573. Yellow filed $137M+ lawsuit against the International Brotherhood of Teamsters, alleging breach of contract in blocking efforts to modernize century-old company.
    • Bruush Oral Care Inc. (NASDAQ:BRSH) fell 22.9% to $0.2575 after gaining around 10% on Monday.
    • Digital Media Solutions, Inc. (NYSE:DMS) fell 21.1% to $0.3215 after jumping around 22% on Monday.
    • Terns Pharmaceuticals, Inc. (NASDAQ:TERN) dropped 17.4% to $7.94. Terns Pharmaceuticals highlighted new preclinical data for TERN-601 program in obesity at the ADA's 83rd Annual Scientific Session and upcoming events.
    • Benitec Biopharma Inc. (NASDAQ:BNTC) fell 16.3% to $0.3012.
    • GSR II Meteora Acquisition Corp. (NASDAQ:GSRM) fell 15.8% to $4.1099.
    • Viking Therapeutics, Inc. (NASDAQ:VKTX) fell 15.7% to $15.29. Truist Securities reiterated Viking Therapeutics with a Buy and maintained a $32 price target.
    • NovaBay Pharmaceuticals, Inc. (NYSE:NBY) dipped 15% to $0.7438.
    • ReShape Lifesciences Inc. (NASDAQ:RSLS) fell 14.1% to $1.52. ReShape Lifesciences submitted FDA PMA supplement application for the next-generation Lap-Band 2.0.
    • iMedia Brands, Inc. (NASDAQ:IMBI) shares dropped 13.6% to $0.1641 after jumping 35% on Monday. iMedia Brands recently announced receipt of second Nasdaq non-compliance notice.
    • Akumin Inc. (NASDAQ:AKU) fell 12.2% to $0.2190.
    • Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) dropped 11.9% to $207.31. Madrigal Pharmaceuticals recently presented Phase 3 MAESTRO-NASH data at the European Association for the Study of the Liver Congress.
    • Spark Networks SE (NASDAQ:LOV) fell 9.5% to $0.3801 after jumping 50% on Monday. Spark Networks recently received notice from Nasdaq advising it has determined to deny the company's request for continued listing.
    • TMC the metals company Inc. (NASDAQ:TMC) declined 9.4% to $1.25.
    • Applied Digital Corporation (NASDAQ:APLD) shares dropped 9.3% to $8.34. Applied Digital sees Q4 revenue of $22 million and net loss of $6.8 million.
    • Walgreens Boots Alliance, Inc. (NASDAQ:WBA) dipped 9.2% to $28.70 after the company lowered its FY23 guidance.
    • Evelo Biosciences, Inc. (NASDAQ:EVLO) shares fell 9% to $0.1820 after gaining around 18% on Monday. Evelo Biosciences recently won U.S. Patent for prebiotic compositions and methods of use thereof for modulation of the microbiome.
    • Acelyrin, Inc. (NASDAQ:SLRN) dropped 8.3% to $21.92.
    • Super Group (SGHC) Limited (NYSE:SGHC) fell 7% to $2.82.
    • TD SYNNEX Corporation (NYSE:SNX) declined 7% to $90.89 after the company reported worse-than-expected second-quarter financial results and issued third-quarter adjusted EPS and revenue guidance below estimates.
    • CureVac N.V. (NASDAQ:CVAC) dropped 6% to $10.91. CureVac recently dosed the first patient in its Phase 1 study of its cancer vaccine candidate for surgically resected glioblastoma.

     

    Now Read This: Bitcoin Rises But Remains Below This Key Level; Bitcoin Cash, Compound Among Top Gainers

    Get the next $ACET alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACET
    $ACIU
    $AEL
    $AKU

    CompanyDatePrice TargetRatingAnalyst
    Xponential Fitness Inc.
    $XPOF
    2/27/2026$7.00Buy → Neutral
    Roth Capital
    Enovix Corporation
    $ENVX
    2/26/2026$15.00 → $7.50Hold
    TD Cowen
    Unity Software Inc.
    $U
    2/10/2026$38.00Perform → Outperform
    Oppenheimer
    Terns Pharmaceuticals Inc.
    $TERN
    2/9/2026$58.00Outperform
    Leerink Partners
    CalciMedica Inc.
    $CALC
    1/29/2026Buy → Neutral
    H.C. Wainwright
    Madrigal Pharmaceuticals Inc.
    $MDGL
    1/28/2026$964.00Overweight
    Barclays
    TD SYNNEX Corporation
    $SNX
    1/13/2026$180.00Buy
    Goldman
    Applied Digital Corporation
    $APLD
    1/7/2026$99.00Buy
    Arete
    More analyst ratings

    $ACET
    $ACIU
    $AEL
    $AKU
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Co-Chief Executive Officer Wang Michael Xue bought $18,529 worth of shares (8,000 units at $2.32), increasing direct ownership by 2% to 461,882 units (SEC Form 4)

    4 - Ispire Technology Inc. (0001948455) (Issuer)

    2/26/26 4:27:49 PM ET
    $ISPR
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Suvretta Capital Management, Llc bought $1,903,133 worth of shares (144,223 units at $13.20) (SEC Form 4)

    4 - Benitec Biopharma Inc. (0001808898) (Issuer)

    12/29/25 7:31:28 PM ET
    $BNTC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Suvretta Capital Management, Llc bought $538,972 worth of shares (46,141 units at $11.68) (SEC Form 4)

    4 - Benitec Biopharma Inc. (0001808898) (Issuer)

    12/22/25 7:45:03 PM ET
    $BNTC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACET
    $ACIU
    $AEL
    $AKU
    SEC Filings

    View All

    Xponential Fitness Inc. filed SEC Form 8-K: Results of Operations and Financial Condition

    8-K - Xponential Fitness, Inc. (0001802156) (Filer)

    2/26/26 4:12:46 PM ET
    $XPOF
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    SEC Form 6-K filed by Moolec Science SA

    6-K - Moolec Science SA (0001937737) (Filer)

    2/26/26 4:01:13 PM ET
    $MLEC
    Blank Checks
    Finance

    SEC Form 10-K filed by Edgewise Therapeutics Inc.

    10-K - Edgewise Therapeutics, Inc. (0001710072) (Filer)

    2/26/26 8:05:45 AM ET
    $EWTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACET
    $ACIU
    $AEL
    $AKU
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nkarta to Participate in March Investor Conferences

    SOUTH SAN FRANCISCO, Calif., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Nkarta, Inc. (NASDAQ:NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat autoimmune diseases, today announced its participation in the following investor conferences: March 2, 2026TD Cowen 46th Annual Health Care ConferenceBoston, MA9:10 a.m. EST – fireside chatMarch 10, 2026Leerink Global Healthcare ConferenceMiami, FL10:40 a.m. EDT – fireside chatA simultaneous webcast of both events will be available on the Investors section of Nkarta's website, and a replay will be archived on the website for approximately 90 days. About NkartaNkarta is a clinical-stage biote

    2/27/26 8:00:00 AM ET
    $NKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Xponential Fitness, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results

    System-wide sales1 of $446.7 million in Q4 2025 increased 5% year-over-year Sold 179 franchise licenses and opened 341 gross new studios in 2025 Xponential Fitness, Inc. (NYSE:XPOF) ("Xponential" or the "Company"), one of the leading global franchisors of boutique health and wellness brands, today reported financial results for the fourth quarter and full year ended December 31, 2025. All financial data included in this release refer to global numbers, unless otherwise noted. All KPI information is presented on an adjusted basis to include full historical data for all brands in the brand portfolio as of December 31, 2025, and to exclude all information for all brands not owned as o

    2/26/26 4:05:00 PM ET
    $XPOF
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Champion Safe Continues to Build Sales Momentum as Sports Inc. Dealers Shift to Enhanced Challenger 20 Safe Model

    Independent retailers place spring orders in Phoenix as Challenger 20 replaces the Sports Inc–exclusive Model T with an integrated 120V outlet and refreshed black-chrome hardware—built with American-made steel Provo, UT, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Champion Safe Company (championsafe.com), a premier manufacturer of high-security safes and a proud subsidiary of American Rebel Holdings, Inc. (NASDAQ:AREB), America's Patriotic Brand™, concluded a successful showing at the Sports Inc Spring Outdoor Show in Phoenix, Arizona, reinforcing its long-standing partnership with Sports Inc buying group dealers and confirming strong spring order momentum across core product lines. The Sports I

    2/26/26 8:30:00 AM ET
    $AREB
    Plastic Products
    Industrials

    $ACET
    $ACIU
    $AEL
    $AKU
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, Chief Financial Officer Yahes Jarrod sold $220,382 worth of shares (12,196 units at $18.07), decreasing direct ownership by 2% to 533,933 units (SEC Form 4)

    4 - Unity Software Inc. (0001810806) (Issuer)

    2/27/26 5:29:17 PM ET
    $U
    Computer Software: Prepackaged Software
    Technology

    Chief Accounting Officer Barrysmith Mark sold $191,144 worth of shares (10,578 units at $18.07), decreasing direct ownership by 3% to 383,901 units (SEC Form 4)

    4 - Unity Software Inc. (0001810806) (Issuer)

    2/27/26 5:24:37 PM ET
    $U
    Computer Software: Prepackaged Software
    Technology

    SVP, Chief Operating Officer Blum Alexander sold $231,333 worth of shares (12,705 units at $18.21), decreasing direct ownership by 2% to 548,425 units (SEC Form 4)

    4 - Unity Software Inc. (0001810806) (Issuer)

    2/27/26 5:20:17 PM ET
    $U
    Computer Software: Prepackaged Software
    Technology

    $ACET
    $ACIU
    $AEL
    $AKU
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Xponential Fitness downgraded by Roth Capital with a new price target

    Roth Capital downgraded Xponential Fitness from Buy to Neutral and set a new price target of $7.00

    2/27/26 8:34:02 AM ET
    $XPOF
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    TD Cowen reiterated coverage on Enovix with a new price target

    TD Cowen reiterated coverage of Enovix with a rating of Hold and set a new price target of $7.50 from $15.00 previously

    2/26/26 6:56:07 AM ET
    $ENVX
    Industrial Machinery/Components
    Miscellaneous

    Unity Software upgraded by Oppenheimer with a new price target

    Oppenheimer upgraded Unity Software from Perform to Outperform and set a new price target of $38.00

    2/10/26 7:17:53 AM ET
    $U
    Computer Software: Prepackaged Software
    Technology

    $ACET
    $ACIU
    $AEL
    $AKU
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for REZDIFFRA issued to MADRIGAL PHARMACEUTICALS INC

    Submission status for MADRIGAL PHARMACEUTICALS INC's drug REZDIFFRA (ORIG-1) with active ingredient RESMETIROM has changed to 'Approval' on 03/14/2024. Application Category: NDA, Application Number: 217785, Application Classification: Type 1 - New Molecular Entity

    3/14/24 3:35:50 PM ET
    $MDGL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    September 12, 2023 - FDA Issues Warning Letters to Firms Marketing Unapproved Eye Products

    For Immediate Release: September 12, 2023 The U.S. Food and Drug Administration has issued warning letters to eight companies for manufacturing or marketing unapproved ophthalmic drug products in violation of federal law. These warning letters are part of the agency’s ongoing effort to protect Americans from potentially harmful ophthalmic products. Eye products addressed in the eight warning letters are illegal

    9/12/23 10:44:21 AM ET
    $WBA
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    FDA Approval for KORSUVA issued to CARA THERAPEUTICS INC

    Submission status for CARA THERAPEUTICS INC's drug KORSUVA (ORIG-1) with active ingredient DIFELIKEFALIN has changed to 'Approval' on 08/23/2021. Application Category: NDA, Application Number: 214916, Application Classification: Type 1 - New Molecular Entity

    8/24/21 12:36:58 PM ET
    $CARA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACET
    $ACIU
    $AEL
    $AKU
    Financials

    Live finance-specific insights

    View All

    Super Group Reports Financial Results for Fourth Quarter and Full Year 2025

    Revenue of $2.2 billion for the year and $578.3 million for the fourth quarter of 2025 Profit before tax of $355.9 million for the year and $95.1 million for the fourth quarter of 2025 Non-GAAP Adjusted EBITDA of $559.5 million for the year and $139.0 million for the fourth quarter of 2025 Cash and cash equivalents of $513.2 million as of December 31, 2025 Minimum quarterly dividend target raised to 5.0 cents per share up from 4.0 cents The Group intends to publish its annual financial statements in early April 2026 Super Group (SGHC) Limited (NYSE:SGHC) ("SGHC", the "Company" or "Super Group"), the parent company of Betway, a leading online sports betting and gaming busi

    2/23/26 4:01:00 PM ET
    $SGHC
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Madrigal Pharmaceuticals Reports Fourth-Quarter and Full-Year 2025 Financial Results

    Fourth-quarter and full-year 2025 Rezdiffra® (resmetirom) net sales of $321.1 million and $958.4 million, respectively As of year-end 2025, more than 36,250 patients on Rezdiffra Built industry-leading MASH pipeline with more than 10 programs at multiple stages of developmentReports cash, cash equivalents, restricted cash and marketable securities of $988.6 million as of Dec. 31, 2025Company to host conference call today, Feb. 19, 2026, at 8 a.m. EST CONSHOHOCKEN, Pa., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today reports

    2/19/26 7:00:00 AM ET
    $MDGL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Xponential Fitness, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 26th

    Xponential Fitness, Inc. (NYSE:XPOF) ("Xponential" or the "Company"), one of the leading global franchisors of boutique health and wellness brands, today announced that it will release its fourth quarter and full year 2025 financial results on Thursday, February 26, 2026, after the market closes. Xponential Fitness management will host a conference call to discuss the results the same day at 1:30 p.m. PT / 4:30 p.m. ET. To access the event by telephone, please dial +1 (877) 407-9716 and provide conference ID 13758051. International callers should dial +1 (201) 493-6779 and provide the same conference ID. The call will also be broadcast live over the Internet and can be accessed in the Inv

    2/12/26 4:05:00 PM ET
    $XPOF
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $ACET
    $ACIU
    $AEL
    $AKU
    Leadership Updates

    Live Leadership Updates

    View All

    Astrotech Reports Second Quarter of Fiscal Year 2026 Financial Results

    AUSTIN, Texas, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ:ASTC) (the "Company" or "Astrotech") reported its financial results for the second quarter of fiscal year 2026, which ended December 31, 2025. Financial Highlights & Recent Developments Research and development expense was $1,832 thousand, a decline of 25% from the second quarter of fiscal year 2025 as the Company transitions from development stage to saleable products for its EN-SCAN Handheld GC and 1st Detect Tracer 1000 product lines.Through December 31, 2025, the Company has deployed the TRACER 1000 trace detection system in approximately 35 locations in 16 countries across the United States, Europe and As

    2/13/26 8:15:00 AM ET
    $ASTC
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Ribo and Ribocure Announce Exclusive Global Licensing Agreement with Madrigal for Novel siRNA Therapeutics Targeting MASH

    SUZHOU, China and MÖLNDAL, Sweden, Feb. 11, 2026 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. (HKEX: 06938) ("Ribo") and its subsidiary Ribocure Pharmaceuticals AB ("Ribocure") today announced that they have entered into an exclusive worldwide licensing agreement with Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) ("Madrigal") for six pre-clinical small interfering RNA (siRNA) programs for the treatment of metabolic dysfunction-associated steatohepatitis (MASH). The collaboration will utilize Ribo's validated liver targeting siRNA GalSTARTM platform to develop novel treatm

    2/11/26 6:25:00 AM ET
    $MDGL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Unity Appoints Bernard Kim to its Board of Directors and Announces Board Transitions

    Unity (NYSE:U), the world's leading game engine, today announced the appointment of gaming and technology veteran Bernard Kim as an independent director to its Board of Directors, effective May 1, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260210709281/en/Bernard Kim "Bernard brings deep experience building and scaling global, public companies at the intersection of games and technology," said Jim Whitehurst, Chairman of Unity's Board of Directors. "His leadership across mobile gaming, advertising technology, and consumer platforms will be a valuable addition to the Unity Board." "Unity plays a foundational role in h

    2/10/26 4:15:00 PM ET
    $U
    Computer Software: Prepackaged Software
    Technology

    $ACET
    $ACIU
    $AEL
    $AKU
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by AC Immune SA

    SC 13G/A - AC Immune SA (0001651625) (Subject)

    12/13/24 5:15:16 PM ET
    $ACIU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Nkarta Inc.

    SC 13G - Nkarta, Inc. (0001787400) (Subject)

    12/13/24 5:02:47 PM ET
    $NKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Benitec Biopharma Inc.

    SC 13G/A - Benitec Biopharma Inc. (0001808898) (Subject)

    12/6/24 1:47:28 PM ET
    $BNTC
    Biotechnology: Pharmaceutical Preparations
    Health Care